IceCure Medical (ICCM) Return on Sales (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Return on Sales data on file, last reported at 0.05% in Q1 2026.

• On a quarterly basis, Return on Sales changed 0.0% year-over-year to 0.05% in Q1 2026; TTM through Mar 2026 was 0.04%, a 7.0% increase from a year earlier, with the FY2025 full-year figure at 0.04%, up 4.0% from the prior year.
• Return on Sales for Q1 2026 stood at 0.05%, up from 0.03% in the prior quarter.
• Over the last five years, Return on Sales for ICCM reached as high as 0.12% in Q3 2023 and fell as low as 0.5% in Q4 2022.
• Historically, Return on Sales has averaged 0.02% across 5 years, with a median of 0.05% in 2024.
• Across the five-year window, Return on Sales slipped 28 bps in 2022 and climbed 25 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.5% in 2022, then increased by 25 bps to 0.37% in 2023, then surged by 41 bps to 0.22% in 2024, then surged by 115 bps to 0.03% in 2025, then jumped by 41 bps to 0.05% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.05% in Q1 2026, 0.03% in Q4 2025, and 0.05% in Q3 2025.